Dilated cardiomyophaty

Cardiovascular diseases are the first cause of death in developed countries. Using electrocardiographic (ECG), blood pressure (BP) and respiratory flow signals, we obtained parameters for classifying cardiomyopathy patients. 42 patients with ischemic (ICM) and dilated (DCM) cardiomyopathies were studied. The left ventricular ejection fraction (LVEF) was used to stratify patients with low risk (LR: LVEF>35%, 14 patients) and high risk (HR: LVEF≤ 35%, 28 patients) of heart attack. RR, SBP and TTot time series were extracted from the ECG, BP and respiratory flow signals, respectively...

Cardiac resynchronization therapy is a non-pharmacological treatment for patients with dilated cardiomyophaty and congestive heart failure. The success of this therapy depends of permanent biventricular stimulation. We report an 84 year-old man, with intermittent loss of biventricular pacemaker stimulation despite having adequate sensing and stimulation thresholds in the right atrium and both ventricles. The problem was solved after correcting some programming parameters.

In present study we describe the clinical case of successful treatment of dilatation cardiomyophaty based on dilatrend using. 32 years old patient with acute heart failure and rhythm dysfunction was active user of alcohol since 1993. At the beginning of treatment 25 mg of dilatrend twice per day was used. The dose was increased monthly by 2.5 mg. After 4 months of treatment clinical signs of disease were eliminated at the daily dose 50 mg of dilatrend. In order to recover from arrhythmia on the seventh month of treatment cardioversion was successfully carried out...